Search results
Biohaven, A Top 2% Stock, Exits 'Stealth Mode' And Hits A Record High
Investor's Business Daily· 1 year agoBiohaven is coming "out of stealth mode," an analyst said Thursday as BHVN stock climbed for a...
Could This News Upset Vertex Pharmaceuticals' Prospects in the Billion-Dollar Pain Management...
Motley Fool via Yahoo Finance· 4 months agoVertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment, and...
Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start...
TechCrunch· 2 months agoAdvances in generative AI have taken the tech world by storm. Biotech investors are making a big bet...
Your future shrimp meal could come from Atarraya’s farming technology
TechCrunch· 2 years agoAtarraya, creator of Shrimpbox, a sustainable “plug-and-play” shrimp farming technology, is swimming...
Cure Ventures debuts with $350M life sciences fund
Pitchbook via Yahoo Finance· 1 year agoFrom left, Cure Ventures managing partners Lou Tartaglia, Richard Lim and David Fallace (Kathy Tarantola Photography/courtesy of Cure Ventures) The formation of new life sciences-focused venture ...
Dear Sophie: How can early-stage startups improve their chances of getting H-1Bs?
TechCrunch ExtraCrunch· 2 years agoHere's another edition of "Dear Sophie," the advice column that answers immigration-related...
